GlassScriptPhysician profile
Arnold R Leiboff
NPI 1154322188
$1,115.14
in general payments reported to CMS, 2019-2025
12 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $287 · 2020: $96.34 · 2021: $66.32 · 2023: $346 · 2024: $173 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $666.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $665.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $308.39 | 2023-2024 | Signia, Interstim |
| Myriad Genetic Laboratories, INC. | $152.22 | 2023-2025 | Myrisk |
| Olympus America INC. | $125.00 | 2019 | |
| Exact Sciences Corporation | $121.98 | 2025 | The Cologuard Plus Collection Kit |
| Acell, INC. | $101.06 | 2019 | |
| Thd America, INC. | $83.12 | 2023 | |
| Ferring Pharmaceuticals INC. | $59.07 | 2020-2021 | |
| Baxter Healthcare | $58.97 | 2020 | |
| Tei Biosciences INC | $45.44 | 2019 | |
| Braintree Laboratories, INC. | $25.74 | 2021 | |
| Baudax Bio INC. | $18.88 | 2020 | |
| Coloplast Corp | $15.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arnold Leiboff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.